Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de documento
País/Região como assunto
Ano de publicação
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 13(2): e0006838, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30802248

RESUMO

Taenia solium is a zoonotic cestode parasite which causes human neurocysticercosis. Pigs transmit the parasite by acting as the intermediate host. An intervention was implemented to control transmission of T. solium by pigs in Dalit communities of Banke District, Nepal. Every 3 months, pigs were vaccinated with the TSOL18 recombinant vaccine (Cysvax, IIL, India)) and, at the same time, given an oral treatment with 30mg/kg oxfendazole (Paranthic 10% MCI, Morocco). The prevalence of porcine cysticercosis was determined in both an intervention area as well as a similar no intervention control area, among randomly selected, slaughter-age pigs. Post mortem assessments were undertaken both at the start and at the end of the intervention. Participants conducting the post mortem assessments were blinded as to the source of the animals being assessed. At the start of the intervention the prevalence of porcine cysticercosis was 23.6% and 34.5% in the control and intervention areas, respectively. Following the intervention, the prevalence of cysticercosis in pigs from the control area was 16.7% (no significant change), whereas no infection was detected after complete slicing of all muscle tissue and brain in animals from the intervention area (P = 0.004). These findings are discussed in relation to the feasibility and sustainability of T. solium control. The 3-monthly vaccination and drug treatment intervention in pigs used here is suggested as an effective and practical method for reducing T. solium transmission by pigs. The results suggest that applying the intervention over a period of years may ultimately reduce the number of tapeworm carriers and thereby the incidence of NCC.


Assuntos
Cisticercose/veterinária , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/transmissão , Vacinas Sintéticas/uso terapêutico , Animais , Antígenos de Helmintos , Benzimidazóis/uso terapêutico , Cisticercose/prevenção & controle , Cisticercose/terapia , Humanos , Incidência , Nepal , Neurocisticercose/prevenção & controle , Neurocisticercose/transmissão , Projetos Piloto , Prevalência , Suínos , Doenças dos Suínos/terapia , Taenia solium , Vacinação/veterinária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA